Male Hormonal Health
Male hormonal health is dominated by one story โ the slow, gradual decline of testosterone from its peak in the early 20s. But it is not just testosterone: cortisol, insulin, thyroid, growth hormone, and estradiol all play important roles, and all shift with age. Unlike female perimenopause, the male transition is so gradual it is rarely recognised at all.
The five stages of male hormonal health
Like females, male sex hormones remain very low through childhood. Testosterone briefly spikes in the first months of life (the 'mini-puberty'), then suppresses until true puberty. Growth hormone and thyroid hormones are the main drivers of development.
- โBrief testosterone spike in early infancy (mini-puberty) โ organises the male reproductive system
- โRapid growth driven by GH and IGF-1
- โAdrenarche โ adrenal androgens (DHEA) rise from around age 7โ8
- โBrain organisation continues โ testosterone's prenatal effects already shape neural architecture
- โ Undescended testes (cryptorchidism) โ affects future fertility and testosterone production
- โ Precocious puberty before age 9
- โ Growth hormone deficiency
- โ Congenital hypogonadism
The HPG axis activates: hypothalamus pulses GnRH โ pituitary releases FSH and LH โ testes produce testosterone. Testosterone rises 20โ30-fold from childhood levels. This drives the full masculinisation of the body and brain.
- โTesticular growth, penile growth โ driven by LH โ testosterone
- โMuscle mass, bone density surge โ testosterone + GH combination
- โVoice deepening โ larynx enlargement driven by testosterone
- โFacial and body hair โ DHT-driven
- โSperm production begins
- โAcne โ sebaceous gland stimulation by androgens
- โBrain changes: increased risk tolerance, reward-seeking, libido onset
- โ Delayed puberty (no testicular growth by age 14) โ may indicate hypogonadism
- โ Gynaecomastia (breast tissue) โ common due to estradiol spike during testosterone rise, usually resolves
- โ Varicocele โ can impair testicular function and fertility
- โ Mental health โ highest onset of anxiety and depression in adolescence
Total testosterone peaks around age 19โ20 and declines gradually โ total testosterone at roughly 1โ2% per year from the late 20s; free testosterone declines somewhat faster as SHBG rises with age. Lifestyle factors โ stress, sleep, metabolic health, body fat โ have an increasingly large impact on hormonal status.
- โTestosterone peaks ~19โ20, free testosterone begins declining from late 20s
- โFertility typically high but sperm quality sensitive to heat, toxins, stress, obesity
- โGH secretion begins its lifelong decline from the mid-20s
- โMetabolic health increasingly shaped by lifestyle โ sleep, stress, diet, exercise
- โVisceral fat accumulation (even modest) reduces testosterone via aromatase conversion to estrogen
- โ Lifestyle-driven testosterone suppression โ obesity, chronic stress, sleep deprivation all lower testosterone significantly
- โ Metabolic syndrome emerging โ insulin resistance, visceral fat, rising blood pressure
- โ Testicular cancer โ peak incidence 25โ35, most treatable when caught early
- โ Fertility decline begins โ sperm DNA fragmentation increases with age and lifestyle factors
- โ Mental health โ depression and suicide risk peak in young adult men, often unrecognised
Unlike female menopause, male hormonal decline is gradual โ total testosterone at roughly 1โ2% per year from the late 20s; free testosterone declines somewhat faster as SHBG rises with age. By the mid-50s, many men have testosterone levels significantly below their peak. Late-onset hypogonadism (clinically low testosterone with symptoms) affects an estimated 10โ40% of men over 45 โ the wide range reflects differing diagnostic criteria across studies. Because the decline is slow, symptoms accumulate quietly and are often attributed to ageing or stress.
- โFree testosterone falls faster than total โ SHBG rises, binding more testosterone
- โEnergy, motivation, drive decline โ testosterone's dopaminergic effects waning
- โMuscle loss (sarcopenia) accelerates โ testosterone supports protein synthesis
- โVisceral fat increases โ creates a vicious cycle (fat โ more aromatase โ more estrogen โ less testosterone)
- โSleep disruption โ testosterone is released in pulses during sleep; poor sleep โ lower testosterone
- โSexual function changes โ reduced libido, erectile changes (often vascular and hormonal)
- โMood changes โ depression, irritability, reduced sense of wellbeing
- โCognitive changes โ testosterone supports spatial memory and processing speed
- โ Late-onset hypogonadism โ total testosterone <300 ng/dL (10.4 nmol/L) with symptoms
- โ Cardiovascular risk โ testosterone decline correlates with increased CVD risk
- โ Bone density โ osteoporosis underdiagnosed in men; testosterone supports bone
- โ Metabolic syndrome โ testosterone deficiency and insulin resistance amplify each other
- โ Depression presenting as irritability, withdrawal, or anhedonia rather than sadness
- โ PSA and prostate health monitoring begins at this stage
Testosterone levels in men over 70 average 30โ50% lower than in young men. DHEA is typically 10โ20% of peak levels. The metabolic, cardiovascular, musculoskeletal, and cognitive consequences of decades of gradual hormone decline become more apparent. Quality of life interventions โ exercise, sleep, nutrition, and where appropriate testosterone therapy โ become increasingly important.
- โSarcopenia โ muscle loss accelerates; testosterone and GH both very low
- โOsteoporosis โ men lose bone density significantly but are rarely screened
- โCognitive decline โ testosterone and estradiol both neuroprotective
- โSexual dysfunction โ libido, erectile function affected by both hormonal and vascular changes
- โFrailty risk โ low testosterone, low GH, low DHEA all contribute
- โIncreased aromatase in visceral fat can cause relative estrogen excess with feminising effects
- โ Frailty syndrome โ combination of muscle loss, fatigue, low activity, slow gait, weight loss
- โ Osteoporosis โ often missed in men; fracture risk high
- โ Benign prostatic hyperplasia (BPH) and prostate cancer monitoring
- โ Cardiovascular disease โ leading cause of death in older men
- โ Depression โ underdiagnosed and undertreated in older men
- โ Thyroid dysfunction โ increasingly common with age in both sexes
Andropause โ the silent transition
Late-onset hypogonadism (clinically low testosterone) affects an estimated 10โ40% of men over 45 but is rarely discussed, rarely tested, and almost never treated. Because the decline is so gradual โ 1โ2% per year โ men adapt and attribute the changes to stress, getting older, or working too hard. The deep-dive guide covers symptoms, labs, treatments, and what the evidence says.
The testosterone-fat-cortisol cycle
Male hormonal decline is not purely biological โ lifestyle factors have an outsized effect on testosterone. And they compound.
Breaking this cycle โ primarily through resistance exercise and visceral fat reduction โ raises testosterone more effectively than most people expect. A 10% reduction in body weight in obese men raises testosterone by ~25%.